Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Kazuhiko, Iwase"'
Autor:
Shun Higashikawa, Shoko Abe, Kazuhiko Iwase, Tomoaki Takemura, Jieshuo Zhang, Tomoyuki Ohkubo, Hisashi Hayashi
Publikováno v:
2022 12th International Congress on Advanced Applied Informatics (IIAI-AAI).
Publikováno v:
2022 12th International Congress on Advanced Applied Informatics (IIAI-AAI).
Autor:
Kawai, Tetsuya, Kazuhiko, Iwase, Takaya, Noriko, Yamaguchi, Yuko, Kishii, Ryuta, Kohno, Yasushi, Kurasaki, Haruaki
Publikováno v:
In Bioorganic & Medicinal Chemistry Letters 15 February 2017 27(4):1045-1049
Autor:
Yuichi Yageta, Yasushi Kohno, Koji Ochiai, Satoshi Takita, Tatsunobu Sumiya, Akira Ohinata, Tokutaro Yasue, Akihiko Kojima, Kazuhiko Iwase, Tetsuya Kishi
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 23:5311-5316
We previously identified KCA-1490 [(−)-6-(7-methoxy-2-trifluoromethyl-pyrazolo[1,5-a]pyridin-4-yl)-5-methyl-4,5-dihydro-3-(2H)-pyridazinone], a dual PDE3/4 inhibitor. In the present study, we found highly potent selective PDE4 inhibitors derived fr
Autor:
Naoki Ando, Noriko Takaya, Yasushi Kohno, Kosuke Tsuda, Yuko Yamaguchi, Masahiro Nomura, Kazuhiko Iwase, Ryuta Kishii, Haruaki Kurasaki, Mariko Shinoyama
Herein we report a scaffold-hopping approach to identify a new scaffold with a zinc binding headgroup. Structural information was used to give novel oxazolidinone-based LpxC inhibitors. In particular, the most potent compound, 23j, showed a low efflu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a39016427b973359e91039c0bbcfad82
https://europepmc.org/articles/PMC4904260/
https://europepmc.org/articles/PMC4904260/
Autor:
Koji Ochiai, David R. Adams, Hitomi Zushi, Naoki Ando, Tokutaro Yasue, Kazuhiko Iwase, Akira Ohinata, Yasushi Kohno, Tetsuya Kishi, Kazunori Fukuchi
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 21:5451-5456
A structural survey of pyrazolopyridine-pyridazinone phosphodiesterase (PDE) inhibitors was made with a view to optimization of their dual PDE3/4-inhibitory activity for respiratory disease applications. These studies identified (−)-6-(7-methoxy-2-
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 10:1451-1454
A series of novel nikkomycin analogue inhibitors of the chitin synthase of fungal cell wall was synthesized and evaluated for their inhibitory activities. Among them, the compound having a phenanthrene group at the terminal amino acid was found to po
Autor:
Kazuhiko Iwase, Shuichi Hirono
Publikováno v:
Journal of Computer-Aided Molecular Design. 13:499-512
We have developed a new program, SUPERPOSE, to superpose two molecules based on the physicochemical properties of functional atoms within individual molecules. SUPERPOSE treats a pseudo-molecule consisting of functional atoms instead of a real molecu
Autor:
David R. Adams, Tetsuya Kishi, Tokutaro Yasue, Satoshi Takita, Tomohiko Eiraku, Yuichi Yageta, Yasushi Kohno, Koji Ochiai, Akihiko Kojima, Kazuhiko Iwase, Akira Ohinata
Publikováno v:
Bioorganicmedicinal chemistry letters. 23(1)
(-)-6-(7-Methoxy-2-(trifluoromethyl)pyrazolo[1,5-a]pyridin-4-yl)-5-methyl-4,5-dihydropyridazin-3(2H)-one (KCA-1490) exhibits moderate dual PDE3/4-inhibitory activity and promises as a combined bronchodilatory/anti-inflammatory agent. N-alkylation of
Autor:
Tetsuya Kishi, Tomohiko Eiraku, Naoki Ando, Yuichi Yageta, Yasushi Kohno, Akihiko Kojima, David R. Adams, Satoshi Takita, Kazuhiko Iwase, Tokutaro Yasue, Koji Ochiai, Akira Ohinata
Publikováno v:
Bioorganicmedicinal chemistry letters. 22(18)
(–)-6-(7-Methoxy-2-trifluoromethylpyrazolo[1,5-a]pyridin-4-yl)-5-methyl-4,5-dihydro-3-(2H)-pyridazinone (KCA-1490) is a dual PDE3/4 inhibitor that exhibits potent combined bronchodilatory and anti-inflammatory activity. Here we show that a 4,4-dime